Experience and Efficacy of Digital Therapeutics in Major Depression
Data scientist in Basel
portfolio_page-template-default,single,single-portfolio_page,postid-3347,bridge-core-3.1.8,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,side_area_uncovered_from_content,overlapping_content,qode-content-sidebar-responsive,qode-theme-ver-30.5,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,qode-portfolio-single-template-4,wpb-js-composer js-comp-ver-7.6,vc_responsive


Major Depression

How do people who have depression use and experience a digital health app



Part of Rewoso’s real-world-evidence insights projects



Realized in R-Statistics, RMarkdown

Studying Experiences and the Efficacy of a Digital Therapeutics in Major Depression

Real-world digital health insights about the user behavior and efficacy of a smartphone application that offers cognitive-behavioral therapy to help people diagnosed with major depression.

This project used real-world data and combined them with digital health device data, investigating the symptom development of patients who are diagnosed with depression and who were newly-prescribed a clinically-approved digital health application ( The results looked promising and aligned with the results that a phase-III randomized clinical trial has found about, and details will be forthcoming at the 2024 DGN congress.

You can read the abstract if it is published at the DGN Congress.